Liquid Biopsies: Implementation in Clinical Trials Through The Development of Clinical Utility, Upcoming Webinar Hosted by Xtalks

Share Article

In this free webinar, the featured speakers will discuss the role of biomarkers and biomarker testing in a world of precision medicine and the history and evolution of liquid biopsy technologies. Attendees will learn about the use of liquid biopsy testing for patients with NSCLC in the clinic and liquid biopsy utility in monitoring therapeutic response.

Noninvasive approaches, commonly termed liquid biopsies, for obtaining genomic biomarker data have rapidly advanced to provide a less-invasive potential alternative for determining the right therapy for each patient based on their tumor, and identifying and monitoring patients in clinical trials.

The oncology therapeutic pipeline has grown substantially over the last decade, with thousands of drug candidates currently in development. A majority of these drug candidates specifically target driver alterations associated with solid tumors. Therefore, accurate biomarker testing is a key component of elucidating the genetic signature of the disease, potential resistance mechanisms, and for identifying the patient population with the greatest potential to elicit more efficacious responses. The conventional approach to obtaining patient samples to study these biomarkers is an invasive tissue biopsy. Recently, noninvasive approaches, commonly termed liquid biopsies, for obtaining genomic biomarker data have rapidly advanced to provide a less-invasive potential alternative for determining the right therapy for each patient based on their tumor, and identifying and monitoring patients in clinical trials.

In this webinar, featured speakers will highlight the role of biomarker identification and testing, the history and advancements in the field of liquid biopsies, and discuss how liquid biopsy testing is currently being applied in a diagnostic setting for patients with tumor types such as non-small cell lung cancer.

Join Steven Anderson, PhD, Chief Scientific Officer, Covance Drug Development and Taylor Jensen, PhD, Director, Research and Development LabCorp in a live webinar on Monday, November 2, 2020 at 10am EST (3pm GMT/UK).

For more information or to register for this event, visit Liquid Biopsies: Implementation in Clinical Trials Through The Development of Clinical Utility.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sydney Perelmutter
Xtalks
+1 (416) 977-6555 x 352
Email >
Visit website